Ozdemir, N. Et Al. 2013. Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients. Journal of B.U.ON. , vol.18, no.4 , 831-837.

Ozdemir, N., AKSOY, S., Sendur, M., Akinci, M., Yazici, O., Budakoglu, B., ... Abali, H.(2013). Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients. Journal of B.U.ON. , vol.18, no.4, 831-837.

Ozdemir, N. Et Al. "Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients," Journal of B.U.ON. , vol.18, no.4, 831-837, 2013

Ozdemir, N. Et Al. "Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients." Journal of B.U.ON. , vol.18, no.4, pp.831-837, 2013

Ozdemir, N. Et Al. (2013) . "Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients." Journal of B.U.ON. , vol.18, no.4, pp.831-837.

@article{article, author={N. Ozdemir Et Al. }, title={Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic breast carcinoma patients}, journal={Journal of B.U.ON.}, year=2013, pages={831-837} }